SCHEMBL32665463

SCHEMBL32665463

Cc1c(C(=O)O)c(C(=O)O)cc2c(C)c(C(=O)O)c(C(=O)O)cc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 3/20 0.48
LDHB P07195 3/20 0.48
KDM4E B2RXH2 4/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
CSNK2A1 P68400 1/20 0.39
CYP3A4 P08684 1/20 0.39
ACHE P22303 1/20 0.39
NOTUM Q6P988 1/20 0.38
GPR35 Q9HC97 1/20 0.37
PDE10A Q9Y233 1/20 0.37
ALDH1A1 P00352 3/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
POLB P06746 1/20 0.36
PRNP P04156 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29115233 0.91 LDHA (0.48) LDHALDHBKDM4EKMT2AMEN1
SCHEMBL756616 0.85 KDM4E (0.45) LDHALDHBKDM4EKMT2AMEN1
SCHEMBL31373145 0.81 KDM4E (0.47) LDHALDHBKDM4EKMT2AMEN1
SCHEMBL14989172 0.81 KDM4E (0.47) LDHALDHBKDM4EKMT2AMEN1
SCHEMBL3030086 0.79 CYP3A4 (0.47) LDHALDHBKDM4EKMT2AMEN1
SCHEMBL10663487 0.79 KDM4E (0.44) LDHALDHBKDM4EKMT2AMEN1
SCHEMBL29927238 0.79 CYP3A4 (0.47) LDHALDHBKDM4EKMT2AMEN1
SCHEMBL5422717 0.78 KDM4E (0.58) LDHAKDM4EKMT2AMEN1GPR35
SCHEMBL6846916 0.78 LDHA (0.61) LDHALDHBKDM4EKMT2AMEN1
SCHEMBL4184562 0.77 CYP3A4 (0.45) LDHALDHBKDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260022138-A1 METAL ORGANIC FRAMEWORKS FOR OLED APPLICATIONS AND METHODS OF USE CONWAY DAVID JONATHAN (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260022138-A1 METAL ORGANIC FRAMEWORKS FOR OLED APPLICATIONS AND METHODS OF USE TRPV3, VDR, TRPC3 LDHA 628/4885LDHB 1084/4885KDM4E 707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.